Oculis (OCS) Institutional Ownership $17.85 +0.05 (+0.28%) Closing price 04:00 PM EasternExtended Trading$17.84 -0.02 (-0.08%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)CurrentInstitutional OwnershipPercentage22.30%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$29.54MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$4.04M Get OCS Insider Trade Alerts Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OCS Institutional Buying and Selling by Quarter Oculis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bellevue Group AG9,700$188K0.0%-31.2%0.022% 8/15/2025 Bank of America Corp DE40,512$786K0.0%+2.2%0.093% 8/14/2025 Acuta Capital Partners LLC106,718$2.07M2.9%-14.6%0.244% 8/13/2025 Bosun Asset Management LLC19,472$378K0.1%N/A0.045% 8/13/2025 Marshall Wace LLP20,253$393K0.0%N/A0.046% 8/8/2025 Geode Capital Management LLC29,436$571K0.0%+27.7%0.067% 7/15/2025 Compagnie Lombard Odier SCmA97,000$1.88M0.0%+11.5%0.222% 5/16/2025 Alyeska Investment Group L.P.131,332$2.50M0.0%N/A0.301% 5/14/2025 Pivotal bioVenture Partners Investment Advisor LLC2,300,774$43.78M35.4%+32.4%5.270% 5/13/2025 SR One Capital Management LP322,500$6.14M1.6%N/A0.739% Get the Latest News and Ratings for OCS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oculis and its competitors with MarketBeat's FREE daily newsletter. 5/13/2025 Aberdeen Group plc1,253,119$23.85M0.0%+24.1%2.870% 5/5/2025 Kestra Private Wealth Services LLC12,322$234K0.0%N/A0.028% 4/16/2025 Compagnie Lombard Odier SCmA87,000$1.66M0.0%-9.1%0.199% 2/17/2025 Citadel Advisors LLC22,911$389K0.0%N/A0.057% 2/17/2025 Bank of America Corp DE28,980$493K0.0%+58.2%0.072% 2/17/2025 Bellevue Group AG10,000$170K0.0%N/A0.025% 2/13/2025 XTX Topco Ltd13,249$225K0.0%N/A0.033% 2/12/2025 Geode Capital Management LLC16,744$284K0.0%+12.0%0.041% 1/24/2025 abrdn plc1,009,424$17.15M0.0%+23.0%2.492% 10/25/2024 abrdn plc820,553$10.06M0.0%-25.4%2.026% 5/14/2024 Nan Fung Group Holdings Ltd436,378$5.26M4.9%-15.9%1.077% 2/14/2024 Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190% 2/6/2024 Searle & CO.10,000$112K0.0%N/A0.027% 1/31/2024 abrdn plc1,452,741$15.98M0.0%N/A3.992% 1/16/2024 Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263% 11/14/2023 Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667% 11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097% 11/13/2023 Wolverine Asset Management LLC7,021$77K0.0%N/A0.019% 9/21/2023 Barclays PLC3,602$44K0.0%N/A0.010% 5/12/2023 Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989% 5/1/2023 Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199% (Data available from 1/1/2016 forward) OCS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OCS shares? During the previous two years, 19 institutional investors and hedge funds held shares of Oculis. The most heavily invested institutionals were Pivotal bioVenture Partners Investment Advisor LLC ($43.78M), Aberdeen Group plc ($23.85M), abrdn plc ($17.15M), SR One Capital Management LP ($6.14M), Nan Fung Group Holdings Ltd ($5.26M), Alyeska Investment Group L.P. ($2.50M), and Acuta Capital Partners LLC ($2.07M).Learn more on Oculis' institutional investors. What percentage of Oculis' stock is owned by institutional investors? 22.30% of Oculis' stock is owned by institutional investors. Learn more on OCS's institutional investor holdings. Which institutional investors have been buying Oculis' stock? Of the 17 institutional investors that purchased Oculis' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: abrdn plc ($1.64M), Pivotal bioVenture Partners Investment Advisor LLC ($563.08K), SR One Capital Management LP ($322.50K), Aberdeen Group plc ($243.70K), Alyeska Investment Group L.P. ($131.33K), Compagnie Lombard Odier SCmA ($40.75K), and Citadel Advisors LLC ($22.91K). How much institutional buying is happening at Oculis? Institutional investors have bought a total of 1,577,412 shares in the last 24 months. This purchase volume represents approximately $29.54M in transactions. Which of Oculis' major shareholders have been selling company stock? The following institutional investors have sold Oculis stock in the last 24 months: abrdn plc ($279.88K), Acuta Capital Partners LLC ($18.28K), Compagnie Lombard Odier SCmA ($8.75K), and Bellevue Group AG ($4.40K). How much institutional selling is happening at Oculis? Institutional investors have sold a total of 311,311 shares in the last 24 months. This volume of shares sold represents approximately $4.04M in transactions. Related Companies BHC Institutional Ownership KYMR Institutional Ownership SRRK Institutional Ownership AMRX Institutional Ownership XENE Institutional Ownership CRNX Institutional Ownership HCM Institutional Ownership RARE Institutional Ownership MOR Institutional Ownership ARWR Institutional Ownership This page (NASDAQ:OCS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access